Brochure | March 8, 2021

Q2 Solutions Pediatric Drug Development Solutions

Source: Q2 Solutions

More pharmaceutical clinical trial studies are enrolling pediatric subjects because they can respond to drugs differently than adults do. New drugs which are intended for use in a pediatric population must be tested and properly evaluated for use in pediatric patients. However, obtaining quality samples with enough volume for testing from very young pediatric subjects can be difficult, and tests are often canceled if samples are received in a clinical laboratory are too low a volume. We recognize the need to reduce the blood volume required in this special population, and we have established policies and procedures specifically tailored for pediatric sample collection and handling.

Our testing assures the best chance for reliable results on very low volume samples. Read in our brochure about our capabilities including established precise low volume blood sample requirements, recommendations for minimum blood volumes by age group, and specialized collection supplies.

VIEW THE BROCHURE!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Clinical Leader